Outcomes4Me
Outcomes4Me is a free cancer support app that empowers patients by integrating FDA-approved treatment guidance from the NCCN Clinical Practice Guidelines with AI to provide personalized cancer treatment options, genetic testing opportunities, symptom tracking, clinical trial access, and understandable health records. The platform supports cancer patients, oncology care providers, and life sciences companies by facilitating informed medical decisions, improving patient care, and accelerating access to treatments and research. Outcomes4Me is oncologist-approved and collaborates globally with cancer care experts, positioning itself as a leading digital tool in cancer care management and patient empowerment.
Outcomes4Me
Outcomes4Me is a free cancer support app that empowers patients by integrating FDA-approved treatment guidance from the NCCN Clinical Practice Guidelines with AI to provide personalized cancer treatment options, genetic testing opportunities, symptom tracking, clinical trial access, and understandable health records. The platform supports cancer patients, oncology care providers, and life sciences companies by facilitating informed medical decisions, improving patient care, and accelerating access to treatments and research. Outcomes4Me is oncologist-approved and collaborates globally with cancer care experts, positioning itself as a leading digital tool in cancer care management and patient empowerment.
TL;DR
Product: AI-driven, evidence-based cancer care platform and free patient mobile/web app
Clinical integration: Integrates NCCN Clinical Practice Guidelines, genomics, clinical-trial matching, and symptom tracking
Founded / HQ: Founded 2017; Boston/Cambridge area
Funding: Series A closed May 29, 2025; total funding reported ~$37.7M
Team size: Approximately 26 employees
Company Overview
Problem Domain
Cancer patient navigation and care decision support
Founded
2017
Industry
Digital health / Health tech
Funding Track Record
4700000.00
Announced raise of $4.7M
12000000.00
Oversubscribed Series A announced
21000000.00
Series A closed May 29, 2025 (reported as $21.0M / Early VC)